Aura Biosciences (AURA) Current Leases (2021 - 2026)

Aura Biosciences has reported Current Leases for 6 years, with the latest figure at $3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 2.99% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (up 2.99% YoY), and the FY2025 full-year result was $3.2 million, up 2.99% from the prior year.
• Current Leases for Q1 2026 stood at $3.3 million, up from $3.2 million in the prior quarter.
• The five-year high for Current Leases was $3.3 million in Q1 2026, with the low at $624000.0 in Q1 2022.
• Historically, Current Leases has averaged $2.7 million across 5 years, with a median of $3.0 million in 2023.
• Annual changes were most pronounced in 2022 — Current Leases jumped 384.68% — and 2023, when it slipped 9.31%.
• Aura Biosciences' Current Leases stood at $3.0 million in 2022, then declined by 9.31% to $2.7 million in 2023, then advanced by 17.19% to $3.1 million in 2024, then increased by 2.99% to $3.2 million in 2025, then rose by 0.74% to $3.3 million in 2026.
• The last three Current Leases figures came in at $3.3 million (Q1 2026), $3.2 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.